article thumbnail

Right to Health and the Issue of Compulsory Licensing for Exorbitantly Priced Risdiplam

SpicyIP

Looking at different flexibilities under the Patent Act, like compulsory licensing, government use etc., Image from here Right to Health and the Issue of Compulsory Licensing for Exorbitantly Priced Risdiplam By Prof. A patented drug, Risdiplam (marketed as Evrysdi), owned by Roche, is effective in managing SMA.

Licensing 105
article thumbnail

Patent Pools, Patent Dealmaking and Outrageously Good Audio

IP Watchdog

This week on IPWatchdog Unleashed we speak with Heath Hoglund, President of Via Licensing Alliance. The conversation takes us deep into the world of audio, video, standard essential patents, patent pools, patent licensing, patent dealmaking, inevitable patent litigation that is often necessary when so much money is at stake, and much more.

Patent 115
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Lenovo Touts UK Wins Against Ericsson in Wireless Device, FRAND Licensing Disputes

IP Watchdog

Telefonaktiebolaget LM Ericsson ruling on the scope of a 2011 wireless device licensing agreement between Motorola (a Lenovo company) and Ericsson. Yesterday, the UKs High Court of Justice of England and Wales (EWHC) issued an approved judgment in Motorola Mobility, LLC v.

article thumbnail

Nokia and Amazon Reach Licensing Deal to End Litigation Over Streaming Patents

IP Watchdog

Nokia announced today that it has signed a deal with Amazon to end all patent litigation between the two companies, the terms of which are confidential.

article thumbnail

Resistance To Patent Licenses Drives More Suits, Execs Say

IP Law 360

Companies that generate revenue from patents are seeing less willingness to negotiate in recent years among businesses they approach about potential licenses, requiring more litigation in order to reach agreements, executives from IBM, InterDigital and others said Monday.

Licensing 105
article thumbnail

Novartis signs Voluntary License Agreement with the Medicine Patent Pool for Nilotinib

IPilogue

In a landmark development , Novartis has signed a Voluntary Licensing Agreement with the Medicine Patent Pool (MPP) for its nilotinib drug, used in treating Chronic Myeloid Leukemia (CML) in adults and children as young as a year old. Patent protection is only one of many factors that hamper this access.

Licensing 119
article thumbnail

Exploring the Differing Views of the ITC and CAFC on ETSI Licensing Declarations

IP Watchdog

focusing, in particular, on the CAFCs findings regarding interpretation and performance of the contractual obligation associated with the licensing declaration utilized by the European Telecommunications Standards Institute (ETSI) as set forth in the ETSI IPR Policy. Lenovo (United States), Inc.